Page last updated: 2024-10-21

4-(2-aminoethyl)benzenesulfonylfluoride and Diabetes Mellitus, Type 1

4-(2-aminoethyl)benzenesulfonylfluoride has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noguchi, H1
Ueda, M1
Hayashi, S1
Kobayashi, N1
Okitsu, T1
Iwanaga, Y1
Nagata, H1
Liu, X1
Kamiya, H1
Levy, MF1
Matsumoto, S1

Other Studies

1 other study available for 4-(2-aminoethyl)benzenesulfonylfluoride and Diabetes Mellitus, Type 1

ArticleYear
Comparison of trypsin inhibitors in preservation solution for islet isolation.
    Cell transplantation, 2009, Volume: 18, Issue:5

    Topics: Adenosine; Allopurinol; Animals; Cell Separation; Diabetes Mellitus, Type 1; Fluorocarbons; Gluconat

2009